Cardiovascular Systems () EBITDA US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | LTM ? | ||||
| EBITDA, bln rub | ? | -0.825 | -25.5 | -10.7 | -34.5 | -35.6 | ||
| Changes by years, y/y, % | -137% | +2 996% | -58% | -100% | ||||
Cardiovascular Systems. EBITDA US GAAP, bln rub
Cardiovascular Systems. EBITDA US GAAP, changes, %
Cardiovascular Systems. EBITDA US GAAP, sum by quarters, bln rub
Cardiovascular Systems () EBITDA US GAAP (quarter values) |
||||||||
| 2022Q1 | 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | LTM ? | |||
| EBITDA, bln rub | ? | -9.59 | -9.30 | -9.14 | -9.02 | -8.18 | -35.6 | |
| Changes by years, y/y, % | +1 878% | +108% | +151% | -6% | ||||
| Changes by quarters, q/q, % | +33% | -3% | -2% | -1% | -9% | |||